Table 5.
Association of breastfeeding with breast cancer recurrence and death, stratified by median expression level of proliferation*
<Median proliferation expression | ≥Median proliferation expression | |||||
---|---|---|---|---|---|---|
Recurrence† | No. events‡ | HR | (95% CI) | No. events‡ | HR | (95% CI) |
Breastfeeding | ||||||
Never | 93 | Ref. | 97 | Ref. | ||
Ever | 87 | 0.58 | (0.37 to 0.93) | 106 | 0.75 | (0.46 to 1.24) |
P interaction = .47 | ||||||
Lifetime breastfeeding | ||||||
Never | 93 | Ref. | 97 | Ref. | ||
<6 mo | 38 | 0.71 | (0.41 to 1.23) | 39 | 0.81 | (0.43 to 1.53) |
≥6 mo | 49 | 0.50 | (0.29 to 0.86) | 67 | 0.72 | (0.40 to 1.27) |
P trend | .03 | .22 | ||||
P interaction = .70 | ||||||
Breast cancer mortality† | ||||||
Breastfeeding | ||||||
Never | 63 | Ref. | 81 | Ref. | ||
Ever | 65 | 0.65 | (0.39 to 1.09) | 81 | 0.71 | (0.40 to 1.25) |
P interaction = .82 | ||||||
Lifetime breastfeeding | ||||||
Never | 63 | Ref. | 81 | Ref. | ||
<6 mo | 32 | 0.85 | (0.45 to 1.59) | 30 | 0.81 | (0.40 to 1.63) |
≥6 mo | 33 | 0.52 | (0.29 to 0.95) | 51 | 0.66 | (0.35 to 1.26) |
P trend | .08 | .20 | ||||
P interaction = .80 |
* n = 29 women had missing data on breastfeeding, parity, surgery, chemotherapy, and/or radiotherapy and were thus excluded from all models. CI = confidence interval; HR = hazard ratio.
† Adjusted for age at diagnosis, race/ethnicity, stage, chemotherapy, radiotherapy, hormonal therapy, surgery type, and parity.
‡ Not population based given case-cohort study design.